Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response — Stella

Home/Primary Biliary Cholangitis/Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

View on ClinicalTrials.gov

Recruiting

Back to Primary Biliary Cholangitis trials

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Peking Union Medical College Hospital, Beijing

Key details

Phase

Post-approval study

Sponsor

Peking Union Medical College Hospital

Enrollment target

~90 participants

Started

January 2020

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.